180 related articles for article (PubMed ID: 35897857)
1. Syntheses and Applications of 1,2,3-Triazole-Fused Pyrazines and Pyridazines.
Hoffman GR; Schoffstall AM
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897857
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a New Series of Nitrogen/Sulfur Heterocycles by Linking Four Rings: Indole; 1,2,4-Triazole; Pyridazine; and Quinoxaline.
Boraei ATA; Sarhan AAM; Yousuf S; Barakat A
Molecules; 2020 Jan; 25(3):. PubMed ID: 31973234
[TBL] [Abstract][Full Text] [Related]
3. Lithium-mediated zincation of pyrazine, pyridazine, pyrimidine, and quinoxaline.
Seggio A; Chevallier F; Vaultier M; Mongin F
J Org Chem; 2007 Aug; 72(17):6602-5. PubMed ID: 17655361
[TBL] [Abstract][Full Text] [Related]
4. Novel Ring Systems: Spiro[Cycloalkane] Derivatives of Triazolo- and Tetrazolo-Pyridazines.
Sepsey Für C; Riszter G; SzigetvárI Á; Dékány M; Keglevich G; HazaI L; BölcskeI H
Molecules; 2021 Apr; 26(8):. PubMed ID: 33917797
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of [1,2,5]chalcogenazolo[3,4-f]benzo[1,2,3]triazole and [1,2,3]triazolo[3,4-g]quinoxaline derivatives.
Tam TL; Li H; Lam YM; Mhaisalkar SG; Grimsdale AC
Org Lett; 2011 Sep; 13(17):4612-5. PubMed ID: 21812401
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytostatic activity of 1,2,4-triazolo- and 1,2,3,4-tetrazolo pyridazines.
Hładoń B; Laskowska H; Sloderbach A; Melzer E
Pol J Pharmacol; 1997; 49(6):471-7. PubMed ID: 9566051
[TBL] [Abstract][Full Text] [Related]
7. Cu/Ag-Mediated One-Pot Enantioselective Synthesis of Fully Decorated 1,2,3-Triazolo[1,5-
Geng ZQ; Zhao C; Qian HD; Li SJ; Peng H; Xu H
Org Lett; 2023 Jun; 25(24):4504-4509. PubMed ID: 37294825
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives.
Nasr MN
Arch Pharm (Weinheim); 2002 Aug; 335(8):389-94. PubMed ID: 12397623
[TBL] [Abstract][Full Text] [Related]
9. Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffold.
Galatsis P; Henderson JL; Kormos BL; Han S; Kurumbail RG; Wager TT; Verhoest PR; Noell GS; Chen Y; Needle E; Berger Z; Steyn SJ; Houle C; Hirst WD
Bioorg Med Chem Lett; 2014 Sep; 24(17):4132-40. PubMed ID: 25113930
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities.
Bindu B; Vijayalakshmi S; Manikandan A
Eur J Med Chem; 2020 Feb; 187():111912. PubMed ID: 31812034
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of 1,2,3-triazole-fused chiral medium-ring benzo-heterocycles, scaffolds mimicking benzolactams.
Das Adhikary N; Chattopadhyay P
J Org Chem; 2012 Jun; 77(12):5399-405. PubMed ID: 22647142
[TBL] [Abstract][Full Text] [Related]
12. A rapid and facile method for the general synthesis of 3-aryl substituted 4,5,6,7-tetrahydro[1,2,3]triazolo[1,5-a]pyrazines and their ring fused analogues.
Chowdhury C; Mukherjee S; Chakraborty B; Achari B
Org Biomol Chem; 2011 Aug; 9(16):5856-62. PubMed ID: 21743898
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the syntheses of N-heterocyclic compounds. X. Syntheses of 2-phenyl-pyrazino(2,3-d)pyridazine derivatives].
Yurugi S; Hieda M
Yakugaku Zasshi; 1972 Nov; 92(11):1322-6. PubMed ID: 4675498
[No Abstract] [Full Text] [Related]
14. Investigations on synthesis and structure elucidation of novel [1,2,4]triazolo[1,2-a]pyridazine-1-thiones and their inhibitory activity against inducible nitric oxide synthase.
Schulz U; Grossmann A; Witetschek M; Lemmerhirt C; Polzin M; Haertel B; Wanka H; Morgenstern O
Bioorg Med Chem; 2013 Sep; 21(17):5518-31. PubMed ID: 23810674
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-b)pyridazines related to formycin prepared via ring closure of pyridazine precursors.
Kang Y; Larson SB; Robins RK; Revankar GR
J Med Chem; 1989 Jul; 32(7):1547-51. PubMed ID: 2738890
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase.
Grey R; Pierce AC; Bemis GW; Jacobs MD; Moody CS; Jajoo R; Mohal N; Green J
Bioorg Med Chem Lett; 2009 Jun; 19(11):3019-22. PubMed ID: 19414255
[TBL] [Abstract][Full Text] [Related]
17. Strategy for the synthesis of pyridazine heterocycles and their derivatives.
Bel Abed H; Mammoliti O; Bande O; Van Lommen G; Herdewijn P
J Org Chem; 2013 Aug; 78(16):7845-58. PubMed ID: 23947534
[TBL] [Abstract][Full Text] [Related]
18. Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors.
Skoumbourdis AP; Leclair CA; Stefan E; Turjanski AG; Maguire W; Titus SA; Huang R; Auld DS; Inglese J; Austin CP; Michnick SW; Xia M; Thomas CJ
Bioorg Med Chem Lett; 2009 Jul; 19(13):3686-92. PubMed ID: 19464886
[TBL] [Abstract][Full Text] [Related]
19. Thiophene Ring-opening Reactions III: One-Pot Synthesis and Antitumor Activity of 1,3,4-Thiadiazoline-Benzothiazolo[3,2-
Abdullah AH; Zahra JA; Sabri SS; Awwadi FF; Abadleh MM; Abdallah QM; El-Abadelah MM
Curr Org Synth; 2022 Mar; 19(2):279-290. PubMed ID: 34751123
[TBL] [Abstract][Full Text] [Related]
20. A novel protocol for catalyst-free synthesis of fused six-member rings to triazole and pyrazole.
Akrami S; Karami B; Farahi M
Mol Divers; 2020 Feb; 24(1):225-231. PubMed ID: 30937596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
